Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Xinan Wang
Clinical Utility of Next-Generation Sequencing-Based Minimal Residual Disease in Paediatric B-Cell Acute Lymphoblastic Leukaemia
British Journal of Haematology
Hematology
Related publications
Measurable Residual Disease (MRD) Detection by Next Generation Sequencing (NGS) in Acute Lymphoblastic LEUKAEMIA (ALL)
Pathology
Forensic Medicine
Pathology
Next-Generation Sequencing in Adult B Cell Acute Lymphoblastic Leukemia Patients
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Transcriptome Analysis of Minimal Residual Disease in Subtypes of Pediatric B Cell Acute Lymphoblastic Leukemia
Clinical Medicine Insights: Oncology
Oncology
Minimal Residual Disease Monitoring With Next-Generation Sequencing Methodologies in Hematological Malignancies
International Journal of Molecular Sciences
Organic Chemistry
Molecular Biology
Theoretical Chemistry
Inorganic Chemistry
Computer Science Applications
Spectroscopy
Medicine
Catalysis
Physical
Minimal Residual Disease by Next-Generation Sequencing in Mantle Cell Lymphoma: The Bioinformatics Tool HashClone
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Metabolomic Profiling Identifies Pathways Associated With Minimal Residual Disease in Childhood Acute Lymphoblastic Leukaemia
EBioMedicine
Biochemistry
Medicine
Genetics
Molecular Biology
Paediatric Acute Lymphoblastic Leukaemia Mimicking Langerhans Cell Histiocytosis of Bone
British Journal of Haematology
Hematology
Molecular Processes Involved in B Cell Acute Lymphoblastic Leukaemia
Cellular and Molecular Life Sciences
Molecular Neuroscience
Molecular Medicine
Cell Biology
Molecular Biology
Pharmacology
Cellular
FDA Approval: Blinatumomab for Patients With B-Cell Precursor Acute Lymphoblastic Leukemia in Morphologic Remission With Minimal Residual Disease
Clinical Cancer Research
Cancer Research
Oncology
